| RS546150528 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS546151500 |
ZNF142
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with impaired speech and hyperkinetic movements, Neurodevelopmental disorder with impaired speech and hyperkinetic movements |
| RS546156675 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALDH18A1-related de Barsy syndrome, Cutis laxa |
| RS546162289 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS546168333 |
ILDR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 42, Autosomal recessive nonsyndromic hearing loss 42 |
| RS546170078 |
PTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Gorlin syndrome |
| RS546172367 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS546174187 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS546189940 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS546203218 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS546206539 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS546207140 |
MYBPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
MYBPC1-related disorder, MYBPC1-related disorder |
| RS546221341 |
POLQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, POLQ-related disorder |
| RS546224817 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546224864 |
POLE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546225564 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS546234840 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS546247674 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS546250852 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS546280073 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS546280470 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS546287338 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease |
| RS546292445 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS546300971 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS546308741 |
COL9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546327568 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
TJP2-related disorder, Hypercholanemia |
| RS546333402 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS546335527 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA5-related disorder, Inborn genetic diseases |
| RS546338962 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546354639 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS546358774 |
TMEM126A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive optic atrophy, OPA7 type |
| RS546359789 |
B9D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS546361762 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS546373462 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS546381069 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS546384224 |
MAPKBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 20, Nephronophthisis 20 |
| RS546399681 |
OSTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 5, Inborn genetic diseases |
| RS546399905 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS546407915 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546411827 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS546427799 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS546431200 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS546437079 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS546442503 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS546450643 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS546461804 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS546463058 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS546463648 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Nephronophthisis |
| RS546468025 |
TAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-thin corpus callosum-intellectual disability syndrome, Microcephaly-thin corpus callosum-intellectual disability syndrome |
| RS546468286 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS546473709 |
COL13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL13A1-related disorder, COL13A1-related disorder |
| RS546484250 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546487084 |
POLR3A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS546493336 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546495818 |
ESRRB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546498421 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS546499094 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS546510242 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS546517702 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS546519295 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly, Thrombomodulin-related bleeding disorder |
| RS546531970 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS546535782 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS546554240 |
CNNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS546554430 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Inborn genetic diseases |
| RS546562229 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS546569747 |
GNAO1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with involuntary movements, Developmental and epileptic encephalopathy |
| RS546573613 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS546574834 |
TMPRSS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcytic anemia, Microcytic anemia |
| RS546575046 |
MYO15A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS546586969 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS546587836 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Medulloblastoma |
| RS546600149 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS546603773 |
ACP4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 1J |
| RS546607673 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
CFI-related disorder, CFI-related disorder |
| RS546618600 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS546621356 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS546629502 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Osteogenesis imperfecta type I |
| RS546630800 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS546643996 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease 2, Moyamoya disease 2 |
| RS546650178 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS546652936 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS546653276 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Recessive dystrophic epidermolysis bullosa |
| RS546653967 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS546660952 |
CYP21A2
|
Health Risk |
Likely pathogenic |
CYP21A2-related disorder, CYP21A2-related disorder |
| RS546662496 |
VWA3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia, autosomal recessive 22 |
| RS546664098 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS546669133 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 4, Cardiovascular phenotype |
| RS546670307 |
CPLANE1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS546675124 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Potassium-aggravated myotonia, Hyperkalemic periodic paralysis |
| RS546679270 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS546681014 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS546681307 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS546682485 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BRCA2-related cancer predisposition |
| RS546692544 |
RPGRIP1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS546693824 |
PPA2
|
Health Risk |
Likely pathogenic |
Sudden cardiac failure, infantile |
| RS546700169 |
DPYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidinase deficiency, Dihydropyrimidinase deficiency |
| RS546702613 |
RAC3
|
Health Risk |
Pathogenic/Likely pathogenic |
RAC3-related disorder, RAC3-related disorder |
| RS546713633 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS546721020 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS546724699 |
IFT81
|
Health Risk |
Pathogenic |
— |